US10806XAB82 · Corp · USD

Bridgebio Pharma Inc 2.50% 2027/03

Bridgebio Pharma IncUnited StatesUS DOMESTICSenior Unsecured
MID PRICE
168.58
par = 100
YIELD TO MAT.
1.48%
semi-annual
COUPON
2.500%
semi-annual · fixed
MATURITY
2027-03-15
bullet · 0.86y
OUTSTANDING
not disclosed
AS OF
2026-05-04

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
0.84 y
1bp ↑ ≈ -0.008% P&L
Convexity
1.14
higher = more curvature
Years to maturity
0.86 y
YTM source
Ingested
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Convertible Bond
iShares
US Convertibles$16.8M▲ $30K0.27%2026-05-04
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-04

Institutional footprint · signal-level holdings

18/ 100Minimal footprint
Interpretation. Minimal institutional footprint, holding
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$16.8M
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
▲ $13K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
168,581 USD
PRICE
168.58

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
BBIO 2 1/2 03/15/27
FIGI
BBG00S6RF7K8
CUSIP
10806XAB8
ISIN
US10806XAB82
Type
Corp
Issued
2020-03-09
Face value
100 USD
Ticker
BBIO 2.5 03/15/27
Sec. type
US DOMESTIC
Seniority
Senior Unsecured

Issuer curve

BBIO · 2 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.